132 related articles for article (PubMed ID: 25755603)
1. Role of external beam radiation therapy in management of hepatocellular carcinoma.
Sharma H
J Clin Exp Hepatol; 2014 Aug; 4(Suppl 3):S122-5. PubMed ID: 25755603
[TBL] [Abstract][Full Text] [Related]
2. Current perspectives on radiotherapy in hepatocellular carcinoma management: a comprehensive review.
Kim D; Kim JS
J Liver Cancer; 2024 Mar; 24(1):33-46. PubMed ID: 38523467
[TBL] [Abstract][Full Text] [Related]
3. The optimal selection of radiotherapy treatment for hepatocellular carcinoma.
Lee IJ; Seong J
Gut Liver; 2012 Apr; 6(2):139-48. PubMed ID: 22570744
[TBL] [Abstract][Full Text] [Related]
4. Proton versus photon radiotherapy for hepatocellular carcinoma: Current data and technical considerations.
Roberts HJ; Hong TS
J Radiosurg SBRT; 2023; 9(1):9-16. PubMed ID: 38029005
[TBL] [Abstract][Full Text] [Related]
5. Leaflet manual of external beam radiation therapy for hepatocellular carcinoma: a review of the indications, evidences, and clinical trials.
Rim CH; Yoon WS
Onco Targets Ther; 2018; 11():2865-2874. PubMed ID: 29844684
[TBL] [Abstract][Full Text] [Related]
6. Hypofractionated particle beam therapy for hepatocellular carcinoma-a brief review of clinical effectiveness.
Hsu CY; Wang CW; Cheng AL; Kuo SH
World J Gastrointest Oncol; 2019 Aug; 11(8):579-588. PubMed ID: 31435460
[TBL] [Abstract][Full Text] [Related]
7. Advances in gross tumor target volume determination in radiotherapy for patients with hepatocellular carcinoma.
Meng K; Gong G; Liu R; Du S; Yin Y
Front Oncol; 2024; 14():1346407. PubMed ID: 38841160
[TBL] [Abstract][Full Text] [Related]
8. Correction to Multicenter retrospective study of stereotactic body radiotherapy for patients with previously untreated initial small hepatocellular carcinoma.
Hepatol Res; 2024 Jan; 54(1):116. PubMed ID: 37957466
[No Abstract] [Full Text] [Related]
9. Risk management in radiation-based therapies.
Bert C
Z Med Phys; 2024 Jun; ():. PubMed ID: 38871495
[No Abstract] [Full Text] [Related]
10. Stereotactic body radiation therapy as an ablative treatment for inoperable hepatocellular carcinoma.
Huertas A; Baumann AS; Saunier-Kubs F; Salleron J; Oldrini G; Croisé-Laurent V; Barraud H; Ayav A; Bronowicki JP; Peiffert D
Radiother Oncol; 2015 May; 115(2):211-6. PubMed ID: 26028227
[TBL] [Abstract][Full Text] [Related]
11. Upgrading prostate cancer following proton beam therapy.
Logan JK; Rais-Bahrami S; Merino MJ; Pinto PA
Urol Ann; 2015; 7(2):262-4. PubMed ID: 25837674
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of normal tissue exposure in patients receiving radiotherapy for pancreatic cancer based on RTOG 0848.
Ling TC; Slater JM; Mifflin R; Nookala P; Grove R; Ly AM; Patyal B; Slater JD; Yang GY
J Gastrointest Oncol; 2015 Apr; 6(2):108-14. PubMed ID: 25830030
[TBL] [Abstract][Full Text] [Related]
13. Normal liver sparing by proton beam therapy for hepatocellular carcinoma: Comparison with helical intensity modulated radiotherapy and volumetric modulated arc therapy.
Kim JY; Lim YK; Kim TH; Cho KH; Choi SH; Jeong H; Kim DW; Park JH; Shin DH; Lee SB; Kim SS; Kim JY; Kim DY; Park JW
Acta Oncol; 2015 Nov; 54(10):1827-32. PubMed ID: 25765526
[No Abstract] [Full Text] [Related]
14. Portal Vein Tumor Thrombosis and Hepatocellular Carcinoma - The Changing Tides.
Khan AR; Wei X; Xu X
J Hepatocell Carcinoma; 2021; 8():1089-1115. PubMed ID: 34522691
[TBL] [Abstract][Full Text] [Related]
15. New horizons in ablation therapy for hepatocellular carcinoma.
Freedman J; Nilsson H; Jonas E
Hepat Oncol; 2015 Oct; 2(4):349-358. PubMed ID: 30191017
[TBL] [Abstract][Full Text] [Related]
16. Pathology and images of radiation-induced hepatitis: a review article.
Takamatsu S; Kozaka K; Kobayashi S; Yoneda N; Yoshida K; Inoue D; Kitao A; Ogi T; Minami T; Kouda W; Kumano T; Fuwa N; Matsui O; Gabata T
Jpn J Radiol; 2018 Apr; 36(4):241-256. PubMed ID: 29508261
[TBL] [Abstract][Full Text] [Related]
17. Stattic Enhances Radiosensitivity and Reduces Radio-Induced Migration and Invasion in HCC Cell Lines through an Apoptosis Pathway.
Xu G; Zhu L; Wang Y; Shi Y; Gong A; Wu C
Biomed Res Int; 2017; 2017():1832494. PubMed ID: 29226125
[TBL] [Abstract][Full Text] [Related]
18. Management of liver cancer. The Surgeon's point of view.
Rabinel P; Dousse D; Muscari F; Suc B
Rep Pract Oncol Radiother; 2017; 22(2):176-180. PubMed ID: 28490990
[TBL] [Abstract][Full Text] [Related]
19. Minimum absolute lymphocyte counts during radiation are associated with a worse prognosis in patients with unresectable hepatocellular carcinoma.
Zhao Q; Xu X; Yue J; Zhu K; Feng R; Jiang S; Qi Z; Wang R
Therap Adv Gastroenterol; 2017 Feb; 10(2):231-241. PubMed ID: 28203281
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Strategies in HCC: Radiation Modalities.
Gallicchio R; Nardelli A; Mainenti P; Nappi A; Capacchione D; Simeon V; Sirignano C; Abbruzzi F; Barbato F; Landriscina M; Storto G
Biomed Res Int; 2016; 2016():1295329. PubMed ID: 27563661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
